Bifidobacterium breve MAK40B22B and Reduced Risk of Crying

• Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial

  • 2019-10-21
  • RCT · n = 236
  • BMC Pediatrics 19(1)
  • • José Maldonado
    • Mercedes Gil-Campos
    • J. Maldonado-Lobón
    • M. R. Benavides
    • K. Flores-Rojas
    • R. Jaldo
    • I. J. D. Barco
    • V. Bolívar
    • A. Valero
    • E. Prados
    • I. Peñalver
    • M. Olivares

  • PubMed: 31630683
  • DOI: 10.1186/s12887-019-1753-7

  8 Insights on

  • Reduced Risk of Crying

  • High evidence
  • Rigorous Journal

  Infants receiving B. breve CECT7263 had a 1.7 times lower risk of crying than the control group (OR = 0.569, CI 95% 0.568-0.571; p = 0.001).

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes